Rafael Rubio

14.2k total citations · 1 hit paper
287 papers, 9.1k citations indexed

About

Rafael Rubio is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Rafael Rubio has authored 287 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Infectious Diseases, 64 papers in Cardiology and Cardiovascular Medicine and 60 papers in Epidemiology. Recurrent topics in Rafael Rubio's work include HIV/AIDS drug development and treatment (62 papers), HIV/AIDS Research and Interventions (58 papers) and HIV Research and Treatment (52 papers). Rafael Rubio is often cited by papers focused on HIV/AIDS drug development and treatment (62 papers), HIV/AIDS Research and Interventions (58 papers) and HIV Research and Treatment (52 papers). Rafael Rubio collaborates with scholars based in Spain, United States and Mexico. Rafael Rubio's co-authors include Robert M. Berne, RM Berne, Richard R. Curnish, H. Richard Winn, Federico Pulido, David G. L. Van Wylen, James G. Dobson, T. S. Park, Guillermo Ceballos and Jorge Navarro and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Rafael Rubio

282 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Release of Adenosine from Ischemic Brain

1974 413 citations Robert M. Berne, Rafael Rubio et al. profile →

Peers

Countries citing papers authored by Rafael Rubio

Since Specialization

Citations

This map shows the geographic impact of Rafael Rubio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Rubio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Rubio more than expected).

Fields of papers citing papers by Rafael Rubio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Rubio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Rubio. The network helps show where Rafael Rubio may publish in the future.

Co-authorship network of co-authors of Rafael Rubio

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael Rubio. A scholar is included among the top collaborators of Rafael Rubio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael Rubio. Rafael Rubio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Application of Artificial Intelligence as an Aid for the Correction of the Objective Structured Clinical Examination (OSCE) 2025 ·Applied Sciences ·(unknown), (unknown), Cristina Calvo, (unknown), Luis Cruz, (unknown), Alfonso Lagares, Rafael Rubio, Juan F. Delgado, (unknown), R.D. Lobato, Jorge D. Martínez, Yale Tung‐Chen, (unknown)	2
2	Healthcare outcomes in patients with HIV infection at a tertiary hospital during the COVID-19 pandemic 2023 ·Enfermedades infecciosas y microbiologia clinica (English ed ) ·Víctor Quirós González, Rafael Rubio, Federico Pulido, (unknown), (unknown), (unknown), Elena López‐Jiménez, (unknown), (unknown), (unknown), Miguel Pedrera‐Jiménez, Noelia García Barrio, Pablo Serrano Balazote, José Luis Bernal Sobrino	2
3	Long-term Evaluation of Residual Viremia in a Clinical Trial of Dolutegravir Plus Lamivudine as Maintenance Treatment for Participants With and Without Prior Lamivudine Resistance 2022 ·Open Forum Infectious Diseases ·Rosa de Miguel Buckley, (unknown), Rocío Montejano, (unknown), María Jiménez-González, María Lagarde, Andrés Esteban-Cantos, (unknown), Julen Cadiñanos, Otilia Bisbal, Juan Castro, (unknown), (unknown), V. Moreno, Asunción Hernando, Luz Martı́n-Carbonero, Rafael Rubio, Rafaël Delgado, José Ramón Arribas, Federico Pulido, (unknown)	7
4	Incidence and Severity of SARS-CoV-2 Infection in HIV-Infected Individuals During the First Year of the Pandemic 2021 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·(unknown), Otilia Bisbal, Rebeca Font, María Lagarde, (unknown), (unknown), (unknown), (unknown), Rafael Rubio, Federico Pulido	8
5	Cryptococcal infection in HIV-infected patients with CD4+ T-cell counts under 100/μL diagnosed in a high-income country: a multicentre cohort study 2020 ·Clinical Microbiology and Infection ·María Asunción Pérez‐Jacoiste Asín, Otilia Bisbal, José Antonio Iribarren, Alfredo Pérez‐Rivilla, Rafael Micán, Fernando Dronda, Carmen María González-Domenech, (unknown), Juan Macı́as, Carlos Lumbreras, Santiago Moreno, Rafael Rubio	3
6	Toward a comprehensive care of HIV patients: finding a strategy to detect depression in a Spanish HIV cohort 2016 ·AIDS Care ·Carmen Bayón, Asunción Hernando, (unknown), (unknown), (unknown), Félix Gutiérrez, Francisco Montesinos, María Lagarde, Otilia Bisbal, Mariano Matarranz, Rafael Rubio, Federico Pulido	3
7	Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial 2015 ·The Lancet Infectious Diseases ·José A. Pérez‐Molina, Rafael Rubio, Antonio Rivero, Juan Pasquau, Ignacio Suárez-Lozano, Melcior Riera, Miriam Estébanez, Jesús Santos, José Sanz, Jesús Troya, Ana Mariño, Antonio Antela, Jordi Navarro, Herminia Esteban, Santiago Moreno	87
8	Definition of Advanced Age in HIV Infection: Looking for an Age Cut-Off 2012 ·AIDS Research and Human Retroviruses ·José Ramón Blanco, Inmaculada Jarrín, (unknown), Juan Berenguer, (unknown), Rafael Rubio, Federico Pulido, Víctor Asensi, Julia del Amo, (unknown)	68
9	Preemptive Erythropoietin Plus High Ribavirin Doses to Increase Rapid Virological Responses in HIV Patients Treated for Chronic Hepatitis C 2010 ·AIDS Research and Human Retroviruses ·Eugenia Vispo, Pablo Labarga, Josep M. Guardiola, Pablo Barreiro, Celia Miralles, Rafael Rubio, Pilar Miralles, Koldo Aguirrebengoa, Joseba Portu, Judit Morelló, Sonia Rodríguez‐Nóvoa, Vincent Soriano	5
10	Characteristics and Outcome of AIDS-Related Hodgkin Lymphoma Before and After the Introduction of Highly Active Antiretroviral Therapy 2008 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Juan Berenguer, Pilar Miralles, Josep‐María Ribera, Rafael Rubio, Eulalia Valencia, Beatriz Mahíllo, Vicente Pintado, Rosario Palacios, Marisa Montes, María Jesús Téllez, (unknown), José Miguel Cisneros, Francisco Rodríguez-Arrondo, (unknown), Félix Gutiérrez, Galo Peralta, Vicente Boix	64
11	Efficacy And Safety of Three Doses of Tipranavir Boosted with Ritonavir in Treatment-Experienced HIV Type 1-Infected Patients 2007 ·AIDS Research and Human Retroviruses ·Joseph Gathe, Gerald Pierone, Peter J. Piliero, Keikawus Arastéh, Rafael Rubio, Richard Lalonde, David A. Cooper, Adriano Lazzarin, Veronika Kohlbrenner, (unknown), John P. Sabo, Douglas L. Mayers	19
12	El camino hacia la excelencia en CRM 2003 ·Rafael Rubio	1
13	Disfunción diastólica en la infección por el virus de la inmunodeficiencia humana 2001 ·Revista Española de Cardiología ·Felipe Hernández, (unknown), Pilar Escribano Subías, Maite Velázquez Martín, (unknown), Carlos Sáenz de la Calzada, Rafael Rubio, Federico Pulido, (unknown)	4
14	Un estudio sobre la soledad en personas mayores: entre el estar solo y el sentirse solo: entre el estar solo y el sentirse solo 2001 ·Rafael Rubio	5
15	Recomendaciones GESIDA/SEFH/PNS para mejorar la adherencia al tratamiento antirretroviral 1999 ·Farmacia Hospitalaria ·C Codina, Hernando Knobel, Júlia Miró, (unknown), (unknown), (unknown), (unknown), Jon Arrizabalaga, (unknown), (unknown), (unknown), Rafael Rubio, (unknown), Pompeyo Viciana	30
16	[Pneumocystis carinii pneumonia and HIV infection: diagnosis and treatment]. 1998 ·PubMed ·Juan González‐García, Rafael Rubio, (unknown), Felipe García	1
17	Widespread dermatophytosis due to Microsporum (Trichophyton) gallinae in a patient with AIDS-a case report from Spain 1992 ·Clinical and Experimental Dermatology ·(unknown), (unknown), (unknown), María Soledad Cuétara, Rafael Rubio, (unknown), (unknown)	12
18	Brain Interstitial Adenosine and Sagittal Sinus Blood Flow during Systemic Hypotension in Piglet 1988 ·Journal of Cerebral Blood Flow & Metabolism ·T. S. Park, David G. L. Van Wylen, Rafael Rubio, Robert M. Berne	26
19	Regulatory function of adenosine : proceedings of the International Symposium on Adenosine, Charlottesville, Virginia, June 7-11, 1982 1983 ·Robert M. Berne, Theodore W. Rall, Rafael Rubio	1
20	The two Staircase Phenomena 1959 ·Archives Internationales de Physiologie et de Biochimie ·A. Rosenblueth, J Alanís, Rafael Rubio, (unknown)	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact